Codexis (CDXS) Non-Current Deffered Revenue (2010 - 2026)
Codexis (CDXS) posted quarterly Non-Current Deffered Revenue of $350000.0 for Q1 2026, down 28.57% year-over-year from $490000.0 in Q1 2025, and down 2.78% quarter-over-quarter from $360000.0 in Q4 2025.
Codexis (CDXS) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends
Codexis' Non-Current Deffered Revenue history runs 17 years deep, the most recent figure standing at $350000.0 for Q1 2026.
- In Q1 2026, Non-Current Deffered Revenue fell 28.57% year-over-year to $350000.0; the TTM figure through Mar 2026 stood at $350000.0 (down 28.57% YoY), while the FY2025 annual figure was $360000.0, up 260.0% from the prior year.
- Non-Current Deffered Revenue for Q1 2026 stood at $350000.0, down from $360000.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $16.9 million in Q4 2022, with the low at $100000.0 in Q4 2024.
- The 5-year median for Non-Current Deffered Revenue is $630000.0 (2024), against an average of $4.2 million.
- The sharpest annual moves came in 2022 and 2024: Non-Current Deffered Revenue soared 350.28% in 2022, then slumped 98.02% in 2024.
- Codexis' Non-Current Deffered Revenue stood at $16.9 million in 2022, then plunged by 96.21% to $640000.0 in 2023, then slumped by 84.38% to $100000.0 in 2024, then surged by 260.0% to $360000.0 in 2025, then dropped by 2.78% to $350000.0 in 2026.
- Business Quant data shows CDXS's Non-Current Deffered Revenue at $350000.0 in Q1 2026, $360000.0 in Q4 2025, and $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 220.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 147.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 350,000.00 |
| Dec 31, 2025 | 360,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 490,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 610,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 630,000.00 |
| Dec 31, 2023 | 640,000.00 |
| Sep 30, 2023 | 10.10 Mn |
| Jun 30, 2023 | 10.11 Mn |
| Mar 31, 2023 | 15.51 Mn |
| Dec 31, 2022 | 16.88 Mn |
| Sep 30, 2022 | 8.24 Mn |
| Jun 30, 2022 | 3.15 Mn |
| Mar 31, 2022 | 3.46 Mn |
| Dec 31, 2021 | 3.75 Mn |
| Sep 30, 2021 | 3.75 Mn |
| Jun 30, 2021 | 3.17 Mn |